Avantor Inc (AVTR) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Avantor Inc   (NYSE: AVTR)

Select the Financial Report: Select the Period:


Description of Avantor Inc's Business Segments


Avantor, Inc. is a global provider of mission-critical products and services for customers in the life sciences, advanced technology, and applied materials industries. Their offerings can be classified into multiple segments, including but not limited to, laboratory supplies, bioprocessing, and specialty chemicals. Below is a detailed exploration of these segments, along with their respective products and services.

Segments, Products, and Services

1. Life Sciences Segment
Avantor supplies a wide array of products and services essential for laboratory operations, research, and development in the life sciences. This segment can be broken down into several categories:

- Laboratory Supplies
Avantor provides pipettes, glassware, plastics, reagents, and consumables essential for day-to-day laboratory operations. Their portfolio includes items like:
- Cell culture products: Media, sera, and supplements required for maintaining and growing cell lines.
- Reagents and standards: A variety of chemicals and biological standards used for testing and analysis.

- Custom Solutions
Tailored products designed to meet specific client needs within the life sciences sector, which may include formulary development and scaling up of production for specialized applications.

- Environmental Health and Safety
Products designed to ensure safety in laboratory settings, including Personal Protective Equipment (PPE), fume hoods, and waste disposal services.

2. Bioprocessing Segment
This segment plays a crucial role in the manufacturing and development of biopharmaceuticals. Avantor’s offerings include:

- Process Development Solutions
Specialized products and services that assist in the development of biotechnological processes, including:
- Chromatography resins and media for protein purification.
- Single-use systems that minimize contamination risks and reduce cleaning costs.

- Manufacturing Support
Avantor aids in the production processes of biopharmaceutical customers by providing:
- Quality control and laboratory services to ensure products meet regulatory standards.
- Logistical support, including supply chain management tailored for the biomanufacturing sector.

3. Applied Materials Segment
This segment addresses the needs of industries like semiconductor manufacturing and advanced materials. Avantor’s products include:

- Specialty Chemicals
High-purity chemicals that meet the stringent requirements of semiconductor fabrication and other precision applications, such as:
- Photoresists for semiconductor manufacturing.
- Cleaning and etching chemicals that ensure the integrity of microelectronicDevices.

- Materials Characterization
Instruments and services that help in analyzing materials to ensure they meet industry specifications and quality standards.

4. Utilities and Services
Avantor also provides various utility services aimed at enhancing operational efficiency, including:

- Supply Chain Solutions
An integrated supply chain network that ensures timely delivery of products, reducing downtime in laboratories and manufacturing plants.

- Technical Support and Training
Avantor offers in-depth technical training programs for laboratory and process operators, ensuring that customers can maximize the utility of their purchased products and services.

5. Digital Solutions
In response to the growing trend towards digital transformation, Avantor has also developed platforms and tools to enhance customer experience and streamline processes. These may include:

- E-commerce Platforms
User-friendly platforms allowing customers to order products online, access product information, and manage their purchases effectively.

- Data Solutions
Tools that help businesses analyze their data related to supply chains, inventory management, and product usage to enhance operational efficiencies.

Conclusion

In summary, Avantor, Inc. offers a comprehensive suite of products and services that cater to a diverse array of industries, including life sciences, bioprocessing, and applied materials. Their extensive portfolio includes laboratory supplies, specialty chemicals, and processes, exemplifying their commitment to supporting scientific advancement and operational efficiency across various sectors.


Composition of Avantor Inc Revenues by Segments

 
Bioscience Medtech Products    27.28 % of total Revenue
VWR Distribution Services    72.72 % of total Revenue
Proprietary    52.69 % of total Revenue
Third-party    47.31 % of total Revenue
Bioscience & Medtech Products    55.85 % of total Revenue
VWR Distribution & Services    151.16 % of total Revenue
Proprietary Materials and Consumables    108.37 % of total Revenue
Third Party Materials and Consumables    98.65 % of total Revenue

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Bioscience Medtech Products 431.40 27.28 %
VWR Distribution Services 1,150.00 72.72 %
Proprietary 833.30 52.69 %
Third-party 748.10 47.31 %
Total 1,581.40 100 %
Bioscience & Medtech Products 883.20 55.85 %
VWR Distribution & Services 2,390.50 151.16 %
Proprietary Materials and Consumables 1,713.70 108.37 %
Third Party Materials and Consumables 1,560.00 98.65 %




Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Bioscience Medtech Products 1.17 % -
VWR Distribution Services -0.43 % -
Proprietary 0.43 % -
Third-party -0.48 % -
Total 0 % -75.86 %
Bioscience & Medtech Products - -
VWR Distribution & Services - -
Proprietary Materials and Consumables - -
Third Party Materials and Consumables - -




Q1 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total 43.30 2.74 %




Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total -32.87 % -




Annual Report on Avantor Inc Divisions, Sales by Country

 
Proprietary   Proprietary Segment contribution to total sales 52.64 % of total Revenue
Third-party   Third-party Segment contribution to total sales 47.36 % of total Revenue
Laboratory Solutions   Laboratory Solutions Segment contribution to total sales 67.15 % of total Revenue
Bioscience Production   Bioscience Production Segment contribution to total sales 32.85 % of total Revenue
United States   United States Segment contribution to total sales 50.05 % of total Revenue
All other countries   All other countries Segment contribution to total sales 49.95 % of total Revenue


Twelve months ended 2025
AVTR s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Proprietary 3,448.90 52.64 %
Third-party 3,103.30 47.36 %
Total 6,552.20 100 %
Laboratory Solutions 4,399.70 67.15 %
Bioscience Production 2,152.50 32.85 %
United States 3,279.70 50.05 %
All other countries 3,272.50 49.95 %


Twelve months ended 2025
AVTR s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -530.20 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Proprietary -4.6 % -
Third-party -2.06 % -
Total -3.41 % -
Laboratory Solutions -4.56 % -
Bioscience Production -0.97 % -
United States -7.6 % -
All other countries 1.19 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.